Advertisement.

NBIO Projected Dividend Yield

Nascent Biotech Inc ( OTCBB : NBIO )

Nascent Biotech is a clinical-stage biopharmaceutical company that develops monoclonal antibodies for the treatment of various forms of cancer. Co. focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and will further develop those drug candidates for commercial use. Co. owns a drug candidate, Pritumumab, which Co. is developing for a group of cancers known as epithelial cancers (which includes lung, breast, colon, brain, and pancreas). Co. is also focused on patients with brain cancer malignancies such as glioblastoma and malignant astrocytoma.

20 YEAR PERFORMANCE RESULTS

NBIO Dividend History Detail
NBIO Dividend News
NBIO Competitors News

# of Shares: 0

Closing Price: 0.06

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000